Diabetes
0A new study has revealed that the use of GLP-1RAs such as semaglutide are “not associated” with an increased risk of suicidality among patients with type 2 diabetes.
0The National Institute for Health and Care Excellence (NICE) has proposed that people with long-term conditions – including obstructive sleep apnoea, schizophrenia and learning disabilities – are weighed annually.
1A West Virginia jury has recommended that no “mercy” be shown to a pharmacist found guilty of murdering her husband to stop him from discovering her Ponzi scheme.
0Community Pharmacy Wales (CPW) has urged pharmacies to “review” weight loss and diabetes prescriptions, after a patient was caught selling extra tirzepatide “mistakenly prescribed” by their GP.
0Amardip Virdi bought the “entire stock” of Ozempic at a pharmacy where he was working during a national shortage to supply it to private weight loss customers, the GPhC’s investigating committee has found.
0A Lloydspharmacy worker who stole Ozempic from the Widnes pharmacy she worked at has been given a suspended sentence of 29 weeks in prison.
0A “thorough review” by the Medicines and Healthcare products Regulatory Agency (MHRA) has found that evidence “does not support” a link between suicidal ideation and diabetes and weight management drug semaglutide.
0The DH has said that patients with type two diabetes can be initiated on or switched to alternative treatments amid ongoing shortages of semaglutide and other GLP-1 RAs.
0A pharmacy technician has been struck off the register for reselling stolen blood sugar tests on eBay and for breaching GDPR by storing “thousands” of prescriptions in her car boot, the General Pharmaceutical Council (GPhC) has revealed.
0Prescribing and dispensing organisations must limit prescriptions to licensed indications only and switch some patients from the injection pens to tablets by March, the government has said.